Skip to main content
Editorial illustration: EHL Cell Clinic: The First Officially Appointed Regenerative Medicine Institute at the Clinic Level
Technology & quality

EHL Cell Clinic: The First Officially Appointed Regenerative Medicine Institute at the Clinic Level

EHL Cell Clinic has been officially appointed by the Ministry of Health and Welfare of Korea as the first regenerative medicine institute at the clinic level, reinforcing its leadership in stem cell and immune cell technology under GMP standards.

2 min readUpdated 12 Oct 2026EHL Thailand editorial team

AI-generated conceptual illustration; not trial results, treatment outcomes or an actual EHL scene.

LINEFacebook

Quick answer

EHL Cell Clinic is the first clinic-level facility to be officially appointed as a Cell Therapy Research Institute by the Korean Ministry of Health and Welfare. It features advanced cell separation and cultivation technology under GMP standards, focusing on rehabilitating degenerative conditions and promoting an 'Aging Well' lifestyle.

Key takeaways

  • Appointed as the first clinic-level regenerative medicine institute by the Korean government.
  • Innovative GMP-standard cell cultivation supporting up to 6,000 lots per year.
  • The first Human Cell Management Business in Korea under the Advanced Regenerative Bio Act.
  • High-purity and efficient cell separation technology from adipose tissue and urine.

A Major Milestone for EHL Cell Clinic as a Research Institute

EHL Cell Clinic, operated by EHL BIO, has been officially recognized by the Ministry of Health and Welfare of the Republic of Korea as the first Cell Therapy Research Institute at the clinic level. This achievement stands as a testament to decades of commitment to continuous stem cell research and development.

Attaining this status allows EHL Cell Clinic to officially initiate advanced regenerative medicine clinical research projects. Governed by the Advanced Regenerative Bio Act, this recognition elevates the standard of medical services for those seeking high-safety restoration alternatives as assessed by the EHL team.

High-Standard Cell Management Technology and Korean Agency Certification

EHL BIO and EHL Cell Clinic are the first in the Republic of Korea to be authorized as a Human Cell Management Business. This covers the entire process from sample collection and safety testing to the processing of stem cells and immune cells.

Utilizing high-level facilities within our GMP center, including Class 100 clean rooms and an integrated Cell Center, we maintain excellent cell survival rates and achieve yields up to 1,000 times higher than industry standards. This ensures that clients receive high-quality cells for restoration goals and quality of life as assessed by the EHL team.

Our goal is to provide health care through advanced regenerative medicine, providing long life and good quality of life to people.

Innovative Stem Cells and Comprehensive Restoration

Our institute focuses on utilizing Mesenchymal Stem Cells (MSCs) extracted from adipose tissue and urine, which are proprietary patented technologies of EHL BIO. These cells possess high proliferation potential and offer safety as autologous (self-derived) services.

The scope of care ranges from age-related degenerative conditions like Osteoarthritis and dementia to immune system care such as Atopic Dermatitis and chronic kidney decline. Currently, products like ADSTEM and KDSTEM are in advanced medical development stages, aiming to promote 'Aging Well' and body restoration through the Homing Effect of stem cells.

Leading Through Research Collaborations

EHL BIO continuously expands its medical collaboration network, partnering with leading university hospitals in Korea to jointly research medical innovations in the Industry 4.0 era.

With a research team of over 85 specialists and production capacities that meet user demands, EHL BIO is poised to lead the biotechnology sector in creating meaningful benefits and quality of life restoration goals for humanity.

Frequently asked questions

How does EHL Cell Clinic differ from general clinics?

EHL Cell Clinic is the first clinic-level regenerative medicine institute officially authorized by the Korean Ministry of Health, featuring its own research center and GMP-standard cell production system.

How safe are the services at this clinic?

We prioritize autologous (self-derived) cells, which reduces immune rejection risks, and conduct cultivation in Class 100 laboratories under high regulatory control in Korea.

What are the restoration and quality of life goals for patients from Thailand?

EHL Thailand provides a Thai-speaking coordination team to handle everything from document evaluation and travel planning to follow-up care after receiving services in Korea, aiming to achieve restoration goals as assessed by the EHL team.

Related conditions

Based on EHL BIO information: EHL BIO · EHL BIO · EHL BIO · EHL BIO. Each care plan follows an individual EHL assessment.

Keep reading

Not sure whether this applies to your case?

Send your questions and initial information through the form. Our team will help prepare your case for an individual assessment with EHL Cell Clinic in Korea.

Consult EHL Thailand